Bromide

Bromide

SCHEMBL3920201

CCCCCCCCCCCCc1cc[n+](C)cc1.[Br-]

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 known ✓ P08172 1/20 0.53
▸ CHRM5 known ✓ P08912 1/20 0.53
▸ CHRM1 known ✓ P11229 1/20 0.53
▸ CHRM3 known ✓ P20309 1/20 0.53
▸ ACHE known ✓ P22303 1/20 0.53
▸ HTR2A P28223 1/20 0.59
▸ ESR1 P03372 2/20 0.53
▸ ADRA2A P08913 2/20 0.53
▸ ADORA3 P0DMS8 2/20 0.53
▸ TACR2 P21452 2/20 0.53
▸ SLC6A2 P23975 2/20 0.53
▸ SLC6A4 P31645 2/20 0.53
▸ SLC6A3 Q01959 2/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ SHBG P04278 1/20 0.53
▸ TP53 P04637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL8656531 1.00 HTR2A (0.59) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL5304765 0.98 HTR2A (0.61) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL5815570 0.98 HTR2A (0.61) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL5303025 0.98 HTR2A (0.61) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL5294380 0.98 HTR2A (0.61) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL5299368 0.98 HTR2A (0.61) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL10645352 0.98 HTR2A (0.61) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL5296180 0.98 HTR2A (0.61) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL5305758 0.98 HTR2A (0.61) HTR2AESR1ADRA2AADORA3TACR2
SCHEMBL5299310 0.98 HTR2A (0.61) HTR2AESR1ADRA2AADORA3TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7488786-B2 emulsion polymerization process for producing a polymer by controlled polymerization which comprises polymerizing at least one monomer in the presence of a free radical control agent THE GOODYEAR TIRE & RUBBER COMPANY (US) 2009-02-10 — — US disclosed
US-7462674-B2 Oxathiazaphospholidine free radical control agent THE GOODYEAR TIRE & RUBBER COMPANY (US) 2008-12-09 — — US disclosed
US-20080097057-A1 Oxathiazaphospholidine free radical control agent THE GOODYEAR TIRE & RUBBER COMPANY (US) 2008-04-24 — — US disclosed
US-7345186-B2 Oxathiazaphospholidine free radical control agent THE GOODYEAR TIRE & RUBBER COMPANY (US) 2008-03-18 — — US disclosed
US-20080033197-A1 Oxathiazaphospholidine free radical control agent THE GOODYEAR TIRE & RUBBER COMPANY (US) 2008-02-07 — — US disclosed
EP-1322674-B1 CONTROL AGENTS FOR LIVING-TYPE FREE RADICAL POLYMERIZATION, METHODS OF POLYMERIZING, EMULSIONS AND POLYMERS WITH SAME SYMYX TECHNOLOGIES INC (US) 2006-11-22 — — EP disclosed
US-20060160774-A1 Oxathiazaphospholidine free radical control agent THE GOODYEAR TIRE & RUBBER COMPANY 2006-07-20 — — US disclosed
US-20040073042-A1 Control agents for living-type free radical polymerization and methods of polymerizing SYMYX TECHNOLOGIES, INC. 2004-04-15 — — US disclosed
US-6667376-B2 Using component having hydroxyamine bonded to thiocarbonyl-sulfide functionality; narrower molecular weight distribu-tion; continuous decrease in polydispersity as monomer conversion increases SYMYX TECHNOLOGIES, INC. 2003-12-23 — — US disclosed
US-20030204034-A1 CONTROL AGENTS FOR LIVING-TYPE FREE RADICAL POLYMERIZATION AND METHODS OF POLYMERIZING SYMYX TECHNOLOGIES, INC. 2003-10-30 — — US disclosed
US-6559255-B2 Using nitrone compound as controller SYMYX TECHNOLOGIES INC. 2003-05-06 — — US disclosed
US-6518364-B2 Subjecting mixture of monomer(s), water, surfactant, free radical source and a control agent to polymerization SYMYX TECHNOLOGIES, INC. 2003-02-11 — — US disclosed
US-6472486-B2 NITROXIDE CONTROL AGENTS HAVING AN ALPHA CARBON ATOM BEARING A DESTABILIZING SUBSTITUENT SUCH AS HYDROGEN SYMYX TECHNOLOGIES, INC. 2002-10-29 — — US disclosed
US-20020065380-A1 Emulsion living-type free radical polymerization, methods and products of same FREESLATE, INC. 2002-05-30 — — US disclosed
US-20020061988-A1 CONTROLLED STABLE FREE RADICAL EMULSION POLYMERIZATION PROCESSES FREESLATE, INC. 2002-05-23 — — US disclosed
WO-2002026836-A2 CONTROL AGENTS FOR LIVING-TYPE FREE RADICAL POLYMERIZATION, METHODS OF POLYMERIZING, EMULSIONS AND POLYMERS WITH SAME SYMYX TECHNOLOGIES, INC. (US) 2002-04-04 — — WO disclosed
US-20020013430-A1 Controlled free radical emulsion and water-based polymerizations and seeded methodologies FREESLATE, INC. 2002-01-31 — — US disclosed
US-20020010267-A1 Polymer segment characterized by a high degree of control over molecular weight, particle size, polydispersity; especially produced using a nitroxide control agent that can be a stable free radical or as an adduct with the initiator SYMYX TECHNOLOGIES, INC., A DELAWARE CORPORATION 2002-01-24 — — US disclosed
EP-1165625-A1 CONTROLLED FREE RADICAL EMULSION AND WATER-BASED POLYMERIZATIONS AND SEEDED METHODOLOGIES Symyx Technologies, Inc. (US) 2002-01-02 — — EP disclosed
WO-2000053640-A1 CONTROLLED FREE RADICAL EMULSION AND WATER-BASED POLYMERIZATIONS AND SEEDED METHODOLOGIES SYMYX TECHNOLOGIES, INC. (US) 2000-09-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160774-A1 Oxathiazaphospholidine free radical control agent AHR, NOX4, ALK CHRM2 1171/4885CHRM5 1363/4885CHRM1 563/4885
US-20080033197-A1 Oxathiazaphospholidine free radical control agent NOX4, AR, AHR CHRM2 1336/4885CHRM5 1478/4885CHRM1 528/4885
US-20040073042-A1 Control agents for living-type free radical polymerization and methods of polymerizing NOX4, CYBB, MB CHRM2 3662/4885CHRM5 4175/4885CHRM1 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback